Nesta is the UK’s innovation foundation with a mission to help people and organisations bring great ideas to life. We are dedicated to supporting ideas that can help improve all our lives, with activities ranging from early stage investment to in-depth research and practical programmes.
We are the lead organisation on Longitude Prize 2014, helping to design, develop and fund the overall project.
Innovate UK is the UK’s innovation agency. They work with people, companies and partner organisations to find and drive the science and technology innovations that will grow the UK economy: delivering productivity, new jobs and exports and keeping the UK globally competitive in the race for future prosperity.
Biotechnology Industry Research Assistance Council or BIRAC aims to stimulate, foster and enhance the strategic research and innovation capabilities of the Indian biotech industry, particularly start-ups and SME’s, for creation of affordable products addressing the needs of the largest section of society.
The BBC is the world's leading public service broadcaster. Its mission is to enrich people's lives with programmes that inform, educate and entertain.
As the home of human ingenuity, with more than 3.3 million visitors annually, the Science Museum is offering in-kind of support to help the Longitude Prize reach more people.
Through its marketing and communication channels, Amazon will help raise awareness and engagement for Longitude Prize.
The National Maritime Museum in Greenwich is the largest museum of its kind in the world. It features extensive galleries and collections, and a learning centre and planetarium all focused on inspirational stories of discovery and adventure at sea.
The National Maritime Museum is running a special exhibition based on the 300th anniversary of the Longitude Prize, and are including a section on the new Longitude Prize.
Marks & Clerk is supporting Longitude Prize through presence on the Longitude Prize Advisory Panel and providing ongoing advice to the Longitude team.
Antibiotic Action is a global initiative established by the British Society for Antimicrobial Chemotherapy (BSAC). We have serious concerns regarding the future effectiveness of currently available antibiotics and the lack of antibiotic agents in the drug pipeline.